Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

New Data Gives Carotid Stenting A Third Shot At Broader Medicare Coverage

This article was originally published in The Gray Sheet

Executive Summary

CMS is again considering whether to expand Medicare coverage for carotid artery stenting

You may also be interested in...



Medicare Panel Looks To Upcoming Study To Fill Evidence Gaps For Carotid Artery Disease

There's a lot more to learn about which treatment to choose for carotid atherosclerosis patients, Medicare advisors said this week. A new trial in the works that would compare both surgery and stenting to standalone medical therapy presents a good opportunity to fill the gaps.

Medicare Panel Looks To Upcoming Study To Fill Evidence Gaps For Carotid Artery Disease

There's a lot more to learn about which treatment to choose for carotid atherosclerosis patients, Medicare advisors said this week. A new trial in the works that would compare both surgery and stenting to standalone medical therapy presents a good opportunity to fill the gaps.

Next Carotid Stenting Coverage Request Could Come This Summer

A cardiology group says it will make a formal request to expand coverage for carotid artery stenting after new consensus clinical guidelines are issued this summer incorporating data from the just-published CREST trial

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT027241

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel